Tag Archives: patient-centric R&D

Why the Slow Take-up of Comparative Effectiveness Research? It's Time and Money, Says a New PCORI Survey

Earlier this week, the federal government’s Patient Centered Outcomes Research Institute (PCORI) unveiled a new survey, revealing that both patients and clinicians want in health research to focus on one thing: improving outcomes. A panel of healthcare providers discussed how findings will impact the structure and content of comparative effectiveness research (CER), advocating patient-centric dissemination […]
Posted in healthcare, Medical Education, Meetings, multimedia, Patient Communication, patient education, Strategy, Technology | Also tagged , , , , , , , | Leave a comment

FDA’s New Breakthrough Designation Process: A Patient Perspective

With the FDA holding its first patient-focused drug development meeting in October of last year, regulators are starting to take notice of the impact disease-based organizations can have in improving drug trial design for new therapies—particularly for rare diseases. According to Teresa Barnes, Vice President of Patient Outreach & Program Support for the Coalition for […]
Posted in FDA, Orphan Drugs, People, R&D, Regulatory, Strategy | Also tagged , , , , , , , , , , , , , , , , | Leave a comment

Medicines Malaise: Sanofi's Fresh Bet on Patient Centric R&D

With a new R&D structure and a high profile appointment to lead it, Sanofi is bidding for leadership in that “new model” the industry is seeking to replenish its anemic pipeline of new products Reinvigorating the productive capacity of in-house R&D is the most prominent strategic challenge confronting big Pharma.  There are many options but […]
Posted in R&D, Strategy | Also tagged , | Leave a comment
  • Categories

  • Meta